Nuwellis, Inc. (NUWE)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. John L. Erb | Interim President, Interim CEO & Chairman of the Board | 49.3k | -- | 1949 |
| Mr. Robert B. Scott | Chief Financial Officer | 269.96k | -- | 1981 |
| Mr. Neil P. Ayotte Esq. | Senior VP, General Counsel, Secretary & Chief Compliance Officer | 306.99k | -- | 1963 |
| Ms. Kim Anderson | Vice President of Operations | -- | -- | -- |
| Betsy Riemenschneider | Vice President of Sales | -- | -- | -- |
| Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. | Chief Medical Officer & Member of Medical Advisory Board | -- | -- | -- |
| Mr. Paul Wotta | Corporate Controller | -- | -- | 1958 |
Nuwellis, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 38
Description
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Corporate Governance
Upcoming Events
August 14, 2025 at 11:30 AM UTC
Nuwellis, Inc. Earnings Date
Recent Events
May 29, 2025 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)